Bill Text: TX SB261 | 2025-2026 | 89th Legislature | Introduced


Bill Title: Relating to the prohibited manufacture, processing, possession, distribution, offer for sale, and sale of cell-cultured protein.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2024-11-12 - Filed [SB261 Detail]

Download: Texas-2025-SB261-Introduced.html
  89R4500 SRA-F
 
  By: Perry S.B. No. 261
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the prohibited manufacture, processing, possession,
  distribution, offer for sale, and sale of cell-cultured protein.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 431.002, Health and Safety Code, is
  amended by adding Subdivision (5-a) to read as follows:
               (5-a)  "Cell-cultured protein" means a food product
  derived from harvesting animal cells and artificially replicating
  those cells in a growth medium to produce tissue.
         SECTION 2.  Section 431.021, Health and Safety Code, is
  amended to read as follows:
         Sec. 431.021.  PROHIBITED ACTS. The following acts and the
  causing of the following acts within this state are unlawful and
  prohibited:
         (a)  the introduction or delivery for introduction into
  commerce of any food, drug, device, or cosmetic that is adulterated
  or misbranded;
         (b)  the adulteration or misbranding of any food, drug,
  device, or cosmetic in commerce;
         (c)  the receipt in commerce of any food, drug, device, or
  cosmetic that is adulterated or misbranded, and the delivery or
  proffered delivery thereof for pay or otherwise;
         (d)  the distribution in commerce of a consumer commodity, if
  such commodity is contained in a package, or if there is affixed to
  that commodity a label that does not conform to the provisions of
  this chapter and of rules adopted under the authority of this
  chapter; provided, however, that this prohibition shall not apply
  to persons engaged in business as wholesale or retail distributors
  of consumer commodities except to the extent that such persons:
               (1)  are engaged in the packaging or labeling of such
  commodities; or
               (2)  prescribe or specify by any means the manner in
  which such commodities are packaged or labeled;
         (e)  the introduction or delivery for introduction into
  commerce of any article in violation of Section 431.084, 431.114,
  or 431.115;
         (f)  the dissemination of any false advertisement;
         (g)  the refusal to permit entry or inspection, or to permit
  the taking of a sample or to permit access to or copying of any
  record as authorized by Sections 431.042-431.044; or the failure to
  establish or maintain any record or make any report required under
  Section 512(j), (l), or (m) of the federal Act, or the refusal to
  permit access to or verification or copying of any such required
  record;
         (h)  the manufacture within this state of any food, drug,
  device, or cosmetic that is adulterated or misbranded;
         (i)  the giving of a guaranty or undertaking referred to in
  Section 431.059, which guaranty or undertaking is false, except by
  a person who relied on a guaranty or undertaking to the same effect
  signed by, and containing the name and address of the person
  residing in this state from whom the person received in good faith
  the food, drug, device, or cosmetic; or the giving of a guaranty or
  undertaking referred to in Section 431.059, which guaranty or
  undertaking is false;
         (j)  the use, removal, or disposal of a detained or embargoed
  article in violation of Section 431.048;
         (k)  the alteration, mutilation, destruction, obliteration,
  or removal of the whole or any part of the labeling of, or the doing
  of any other act with respect to a food, drug, device, or cosmetic,
  if such act is done while such article is held for sale after
  shipment in commerce and results in such article being adulterated
  or misbranded;
         (l)(1)  forging, counterfeiting, simulating, or falsely
  representing, or without proper authority using any mark, stamp,
  tag, label, or other identification device authorized or required
  by rules adopted under this chapter or the regulations promulgated
  under the provisions of the federal Act;
               (2)  making, selling, disposing of, or keeping in
  possession, control, or custody, or concealing any punch, die,
  plate, stone, or other thing designed to print, imprint, or
  reproduce the trademark, trade name, or other identifying mark,
  imprint, or device of another or any likeness of any of the
  foregoing on any drug or container or labeling thereof so as to
  render such drug a counterfeit drug;
               (3)  the doing of any act that causes a drug to be a
  counterfeit drug, or the sale or dispensing, or the holding for sale
  or dispensing, of a counterfeit drug;
         (m)  the using by any person to the person's own advantage,
  or revealing, other than to the department, to a health authority,
  or to the courts when relevant in any judicial proceeding under this
  chapter, of any information acquired under the authority of this
  chapter concerning any method or process that as a trade secret is
  entitled to protection;
         (n)  the using, on the labeling of any drug or device or in
  any advertising relating to such drug or device, of any
  representation or suggestion that approval of an application with
  respect to such drug or device is in effect under Section 431.114 or
  Section 505, 515, or 520(g) of the federal Act, as the case may be,
  or that such drug or device complies with the provisions of such
  sections;
         (o)  the using, in labeling, advertising or other sales
  promotion of any reference to any report or analysis furnished in
  compliance with Sections 431.042-431.044 or Section 704 of the
  federal Act;
         (p)  in the case of a prescription drug distributed or
  offered for sale in this state, the failure of the manufacturer,
  packer, or distributor of the drug to maintain for transmittal, or
  to transmit, to any practitioner licensed by applicable law to
  administer such drug who makes written request for information as
  to such drug, true and correct copies of all printed matter that is
  required to be included in any package in which that drug is
  distributed or sold, or such other printed matter as is approved
  under the federal Act. Nothing in this subsection shall be
  construed to exempt any person from any labeling requirement
  imposed by or under other provisions of this chapter;
         (q)(1)  placing or causing to be placed on any drug or device
  or container of any drug or device, with intent to defraud, the
  trade name or other identifying mark, or imprint of another or any
  likeness of any of the foregoing;
               (2)  selling, dispensing, disposing of or causing to be
  sold, dispensed, or disposed of, or concealing or keeping in
  possession, control, or custody, with intent to sell, dispense, or
  dispose of, any drug, device, or any container of any drug or
  device, with knowledge that the trade name or other identifying
  mark or imprint of another or any likeness of any of the foregoing
  has been placed thereon in a manner prohibited by Subdivision (1);
  or
               (3)  making, selling, disposing of, causing to be made,
  sold, or disposed of, keeping in possession, control, or custody,
  or concealing with intent to defraud any punch, die, plate, stone,
  or other thing designed to print, imprint, or reproduce the
  trademark, trade name, or other identifying mark, imprint, or
  device of another or any likeness of any of the foregoing on any
  drug or container or labeling of any drug or container so as to
  render such drug a counterfeit drug;
         (r)  dispensing or causing to be dispensed a different drug
  in place of the drug ordered or prescribed without the express
  permission in each case of the person ordering or prescribing;
         (s)  the failure to register in accordance with Section 510
  of the federal Act, the failure to provide any information required
  by Section 510(j) or (k) of the federal Act, or the failure to
  provide a notice required by Section 510(j)(2) of the federal Act;
         (t)(1)  the failure or refusal to:
                     (A)  comply with any requirement prescribed under
  Section 518 or 520(g) of the federal Act; or
                     (B)  furnish any notification or other material or
  information required by or under Section 519 or 520(g) of the
  federal Act;
               (2)  with respect to any device, the submission of any
  report that is required by or under this chapter that is false or
  misleading in any material respect;
         (u)  the movement of a device in violation of an order under
  Section 304(g) of the federal Act or the removal or alteration of
  any mark or label required by the order to identify the device as
  detained;
         (v)  the failure to provide the notice required by Section
  412(b) or 412(c), the failure to make the reports required by
  Section 412(d)(1)(B), or the failure to meet the requirements
  prescribed under Section 412(d)(2) of the federal Act;
         (w)  except as provided under Subchapter M of this chapter
  and Section 562.1085, Occupations Code, the acceptance by a person
  of an unused prescription or drug, in whole or in part, for the
  purpose of resale, after the prescription or drug has been
  originally dispensed, or sold;
         (x)  engaging in the wholesale distribution of drugs or
  operating as a distributor or manufacturer of devices in this state
  without obtaining a license issued by the department under
  Subchapter I, L, or N, as applicable;
         (y)  engaging in the manufacture of food in this state or
  operating as a warehouse operator in this state without having a
  license as required by Section 431.222 or operating as a food
  wholesaler in this state without having a license under Section
  431.222 or being registered under Section 431.2211, as appropriate;
         (z)  unless approved by the United States Food and Drug
  Administration pursuant to the federal Act, the sale, delivery,
  holding, or offering for sale of a self-testing kit designed to
  indicate whether a person has a human immunodeficiency virus
  infection, acquired immune deficiency syndrome, or a related
  disorder or condition;
         (aa)  making a false statement or false representation in an
  application for a license or in a statement, report, or other
  instrument to be filed with or requested by the department under
  this chapter;
         (bb)  failing to comply with a requirement or request to
  provide information or failing to submit an application, statement,
  report, or other instrument required by the department;
         (cc)  performing, causing the performance of, or aiding and
  abetting the performance of an act described by Subsection (x);
         (dd)  purchasing or otherwise receiving a prescription drug
  from a pharmacy in violation of Section 431.411(a);
         (ee)  selling, distributing, or transferring a prescription
  drug to a person who is not authorized under state or federal law to
  receive the prescription drug in violation of Section 431.411(b);
         (ff)  failing to deliver prescription drugs to specified
  premises as required by Section 431.411(c);
         (gg)  failing to maintain or provide pedigrees as required by
  Section 431.412 or 431.413;
         (hh)  failing to obtain, pass, or authenticate a pedigree as
  required by Section 431.412 or 431.413;
         (ii)  the introduction or delivery for introduction into
  commerce of a drug or prescription device at a flea market;
         (jj)  the receipt of a prescription drug that is adulterated,
  misbranded, stolen, obtained by fraud or deceit, counterfeit, or
  suspected of being counterfeit, and the delivery or proffered
  delivery of such a drug for payment or otherwise; [or]
         (kk)  the alteration, mutilation, destruction,
  obliteration, or removal of all or any part of the labeling of a
  prescription drug or the commission of any other act with respect to
  a prescription drug that results in the prescription drug being
  misbranded; or
         (ll)  the manufacture, processing, possession,
  distribution, offer for sale, or sale of cell-cultured protein.
         SECTION 3.  Section 431.081, Health and Safety Code, is
  amended to read as follows:
         Sec. 431.081.  ADULTERATED FOOD. A food shall be deemed to
  be adulterated:
         (a)  if:
               (1)  it bears or contains any poisonous or deleterious
  substance which may render it injurious to health; but in case the
  substance is not an added substance the food shall not be considered
  adulterated under this subdivision if the quantity of the substance
  in the food does not ordinarily render it injurious to health;
               (2)  it:
                     (A)  bears or contains any added poisonous or
  added deleterious substance, other than one that is a pesticide
  chemical in or on a raw agricultural commodity, a food additive, a
  color additive, or a new animal drug which is unsafe within the
  meaning of Section 431.161;
                     (B)  is a raw agricultural commodity and it bears
  or contains a pesticide chemical which is unsafe within the meaning
  of Section 431.161(a);
                     (C)  is, or it bears or contains, any food
  additive which is unsafe within the meaning of Section 431.161(a);
  provided, that where a pesticide chemical has been used in or on a
  raw agricultural commodity in conformity with an exemption granted
  or a tolerance prescribed under Section 431.161(a), and such raw
  agricultural commodity has been subjected to processing such as
  canning, cooking, freezing, dehydrating, or milling, the residue of
  such pesticide chemical remaining in or on such processed food
  shall, notwithstanding the provisions of Section 431.161 and
  Section 409 of the federal Act, not be deemed unsafe if such residue
  in or on the raw agricultural commodity has been removed to the
  extent possible in good manufacturing practice, and the
  concentration of such residue in the processed food, when ready to
  eat, is not greater than the tolerance prescribed for the raw
  agricultural commodity; or
                     (D)  is, or it bears or contains, a new animal
  drug, or a conversion product of a new animal drug, that is unsafe
  under Section 512 of the federal Act;
               (3)  it consists in whole or in part of a diseased,
  contaminated, filthy, putrid, or decomposed substance, or if it is
  otherwise unfit for foods;
               (4)  it has been produced, prepared, packed or held
  under unsanitary conditions whereby it may have become contaminated
  with filth, or whereby it may have been rendered diseased,
  unwholesome, or injurious to health;
               (5)  it is, in whole or in part, the product of a
  diseased animal, an animal which has died otherwise than by
  slaughter, or an animal that has been fed upon the uncooked offal
  from a slaughterhouse;
               (6)  its container is composed, in whole or in part, of
  any poisonous or deleterious substance which may render the
  contents injurious to health; [or]
               (7)  it has been intentionally subjected to radiation,
  unless the use of the radiation was in conformity with a regulation
  or exemption in effect in accordance with Section 409 of the federal
  Act; or
               (8)  it contains, in whole or in part, cell-cultured
  protein;
         (b)  if:
               (1)  any valuable constituent has been in whole or in
  part omitted or abstracted therefrom;
               (2)  any substance has been substituted wholly or in
  part therefor;
               (3)  damage or inferiority has been concealed in any
  manner;
               (4)  any substance has been added thereto or mixed or
  packed therewith so as to increase its bulk or weight, or reduce its
  quality or strength or make it appear better or of greater value
  than it is;
               (5)  it contains saccharin, dulcin, glucin, or other
  sugar substitutes except in dietary foods, and when so used shall be
  declared; or
               (6)  it be fresh meat and it contains any chemical
  substance containing sulphites, sulphur dioxide, or any other
  chemical preservative which is not approved by the United States
  Department of Agriculture, the Animal and Plant Health Inspection
  Service (A.P.H.I.S.) or by department rules;
         (c)  if it is, or it bears or contains, a color additive that
  is unsafe under Section 431.161(a); or
         (d)  if it is confectionery and:
               (1)  has any nonnutritive object partially or
  completely imbedded in it; provided, that this subdivision does not
  apply if, in accordance with department rules, the object is of
  practical, functional value to the confectionery product and would
  not render the product injurious or hazardous to health;
               (2)  bears or contains any alcohol, other than alcohol
  not in excess of five percent by volume. Any confectionery that
  bears or contains any alcohol in excess of one-half of one percent
  by volume derived solely from the use of flavoring extracts and less
  than five percent by volume:
                     (A)  may not be sold to persons under the legal age
  necessary to consume an alcoholic beverage in this state;
                     (B)  must be labeled with a conspicuous, readily
  legible statement that reads, "Sale of this product to a person
  under the legal age necessary to consume an alcoholic beverage is
  prohibited";
                     (C)  may not be sold in a form containing liquid
  alcohol such that it is capable of use for beverage purposes as that
  term is used in the Alcoholic Beverage Code;
                     (D)  may not be sold through a vending machine;
                     (E)  must be labeled with a conspicuous, readily
  legible statement that the product contains not more than five
  percent alcohol by volume; and
                     (F)  may not be sold in a business establishment
  which derives less than 50 percent of its gross sales from the sale
  of confectioneries; or
               (3)  bears or contains any nonnutritive substance;
  provided, that this subdivision does not apply to a nonnutritive
  substance that is in or on the confectionery by reason of its use
  for a practical, functional purpose in the manufacture, packaging,
  or storage of the confectionery if the use of the substance does not
  promote deception of the consumer or otherwise result in
  adulteration or misbranding in violation of this chapter; and
  provided further, that the executive commissioner may, for the
  purpose of avoiding or resolving uncertainty as to the application
  of this subdivision, adopt rules allowing or prohibiting the use of
  particular nonnutritive substances.
         SECTION 4.  Subchapter D, Chapter 433, Health and Safety
  Code, is amended by adding Section 433.057 to read as follows:
         Sec. 433.057.  PROHIBITION ON CELL-CULTURED PROTEIN. (a)
  In this section, "cell-cultured protein" has the meaning assigned
  by Section 431.002.
         (b)  A person may not manufacture, process, possess,
  distribute, offer for sale, or sell cell-cultured protein.
         (c)  To the extent another state law conflicts with this
  section, this section controls.
         SECTION 5.  As soon as practicable after the effective date
  of this Act, the executive commissioner of the Health and Human
  Services Commission shall adopt any rules necessary to implement
  the changes in law made by this Act.
         SECTION 6.  This Act takes effect September 1, 2025.
feedback